title: Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.
abstract: BACKGROUND
  Impulsive physical aggression is a common and problematic feature of many personality disorders. The serotonergic system is known to be involved in the pathophysiology of aggression, and multiple lines of evidence have implicated the serotonin 2A receptor (5-HT(2A)R). We sought to examine the role of the 5-HT(2A)R in impulsive aggression specifically in the orbitofrontal cortex (OFC), given that our own studies and an extensive literature indicate that serotonergic disturbances in the OFC are linked to aggression. We have previously hypothesized that increased 5-HT(2A)R function in the OFC is a state phenomenon that promotes impulsive aggression.
  
  
  METHODS
  Serotonin 2A receptor availability was measured with positron emission tomography and the selective 5-HT(2A)R antagonist radioligand [(11)C]MDL100907 in two groups of impulsively aggressive personality disordered patients-14 with current physical aggression, and 15 without current physical aggression-and 25 healthy control subjects. Clinical ratings of various symptom dimensions were also obtained.
  
  
  RESULTS
  Orbitofrontal 5-HT(2A)R availability was greater in patients with current physical aggression compared with patients without current physical aggression and healthy control subjects; no differences in OFC 5-HT(2A)R availability were observed between patients without current physical aggression and healthy control subjects. No significant differences in 5-HT(2A)R availability were observed in other brain regions examined. Among both groups of impulsively aggressive personality disordered patients combined, OFC 5-HT(2A)R availability was correlated, specifically, with a state measure of impulsive aggression.
  
  
  CONCLUSIONS
  These findings are consistent with our previously described model in which impulsive aggression is related to dynamic changes in 5-HT(2A)R function in the OFC.
authors.affiliation: James J. Peters Veterans Affairs Medical Center, Bronx, New York, NY, USA.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Rosell
authors.forename: Judy L
authors.initials: JL
authors.lastname: Thompson
authors.forename: Mark
authors.initials: M
authors.lastname: Slifstein
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Xu
authors.forename: W Gordon
authors.initials: WG
authors.lastname: Frankle
authors.forename: Antonia S
authors.initials: AS
authors.lastname: New
authors.forename: Marianne
authors.initials: M
authors.lastname: Goodman
authors.forename: Shauna R
authors.initials: SR
authors.lastname: Weinstein
authors.forename: Marc
authors.initials: M
authors.lastname: Laruelle
authors.forename: Anissa
authors.initials: A
authors.lastname: Abi-Dargham
authors.forename: Larry J
authors.initials: LJ
authors.lastname: Siever
mesh_terms: D000328:Adult; D000374:Aggression / Q000523:psychology*; D002250:Carbon Radioisotopes / Q000032:analysis; D005260:Female; D005464:Fluorobenzenes / Q000032:analysis; D005625:Frontal Lobe / Q000378:metabolism*; D006801:Humans; D007175:Impulsive Behavior / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010554:Personality Disorders / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000378:metabolism*; D010880:Piperidines / Q000032:analysis; D049268:Positron-Emission Tomography / Q000379:methods; D011869:Radioligand Assay / Q000379:methods; D044402:Receptor, Serotonin, 5-HT2A / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000032:analysis
chemical_list: D002250:Carbon Radioisotopes; D005464:Fluorobenzenes; D010880:Piperidines; D044402:Receptor, Serotonin, 5-HT2A; D012702:Serotonin Antagonists; C079049:volinanserin